当前位置: X-MOL 学术Russ. Chem. Bull. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
New 1-(2-chloroquinolin-3-yl)-4-dimethylamino-2-(naphthalen-1-yl)-1-phenylbutan-2-ols with antituberculosis activity
Russian Chemical Bulletin ( IF 1.7 ) Pub Date : 2019-10-01 , DOI: 10.1007/s11172-019-2646-5
A. V. Omel’kov , V. E. Fedorov , A. A. Stepanov

New 4-dimethylamino-2-(naphthalen-1-yl)-1-phenyl-1-(quinolin-3-yl)butan-2-ols with antituberculosis activity were synthesized. (1R*,2S*)-1-(6-Bromo-2-chloroquinolin-3-yl)-4-dimethylamino-2-(naphthalen-1-yl)-1-phenylbutan-2-ol hydrocitrate exhibiting high antituberculosis activity is in the final stage of clinical trials and is prepared for use in clinical practice.

中文翻译:

具有抗结核活性的新型 1-(2-chloroquinolin-3-yl)-4-dimethylamino-2-(naphthalen-1-yl)-1-phenylbutan-2-ols

合成了具有抗结核活性的新型4-二甲氨基-2-(naphthalen-1-yl)-1-phenyl-1-(quinolin-3-yl)butan-2-ols。(1R*,2S*)-1-(6-Bromo-2-chloroquinolin-3-yl)-4-dimethylamino-2-(naphthalen-1-yl)-1-phenylbutan-2-ol hydrocitrate 具有高抗结核活性处于临床试验的最后阶段,准备用于临床实践。
更新日期:2019-10-01
down
wechat
bug